Zobrazeno 1 - 10
of 55
pro vyhledávání: '"MF Guerra"'
Autor:
AA Belda Cuesta, Manuel Rodríguez-Téllez, P. Hergueta Delgado, VA Jiménez García, T Matsuda, Á Caunedo Álvarez, MF Guerra Veloz
Publikováno v:
ESGE Days 2018 accepted abstracts.
Autor:
M Belvis Jimenez, Jesús Loscertales, M Congregado Loscertales, F. J. Pellicer Bautista, MF Guerra Veloz, H. Galera-Ruiz, Manuel Rodríguez-Téllez, M Jose González-Mariscal
Publikováno v:
ESGE Days 2018 accepted abstracts.
Autor:
MF Guerra Veloz, M A Calleja Hernandez, B Maldonado Pérez, A Vilches Arenas, A Saez Diaz, A. Benítez Roldán, R Perea Amarillo, L Castro Laria, Á Caunedo Álvarez, M Belvis Jimenez, V Merino Bohorquez, Federico Argüelles-Arias, T Valdes Delgado, Tamara Ortiz
Publikováno v:
Journal of Crohn's and Colitis. 13:S303-S304
Autor:
MJ González-Mariscal, Manuel Rodríguez-Téllez, J Loscertales, FJ Pellicer-Bautista, G Walsen, M Belvis, H. Galera-Ruiz, M Congregado, MF Guerra
Publikováno v:
XXXIX Congreso Nacional de la Sociedad Española de Endoscopia Digestiva.
Autor:
Ángel Vilches-Arenas, M. Romero Gómez, V Merino, MF Guerra Veloz, L Castro Laria, Guillermo Ramírez, A. Benítez Roldán, D. Chaaro, Federico Argüelles-Arias, Á Caunedo Álvarez, R Perea Amarillo, B Maldonado Pérez
CT-P13 is a biosimilar of Remicade®, an agent approved in some countries for use in inflammatory bowel disease (IBD). Controlled clinical trials have demonstrated the efficacy and safety of CT-P13 in rheumatic diseases, but not in IBD. To assess the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b43545997356950c596ff12cb091f56
https://hdl.handle.net/10668/11357
https://hdl.handle.net/10668/11357
Publikováno v:
Endoscopy. 48
Autor:
Enrico D; Department of Medical Oncology, Alexander Fleming Cancer Institute, Buenos Aires, Argentina. Electronic address: denrico@alexanderfleming.org., Gomez JE; Department of Medical Oncology, Alexander Fleming Cancer Institute, Buenos Aires, Argentina., Aguirre D; Department of Medical Oncology, Alexander Fleming Cancer Institute, Buenos Aires, Argentina., Tissera NS; Department of Medical Oncology, Upper Gastrointestinal and Endocrine Tumor Group, Vall´d Hebron Institute of Oncology (VHIO), Barcelona, Spain., Tsou F; Department of Medical Oncology, Alexander Fleming Cancer Institute, Buenos Aires, Argentina., Pupareli C; Department of Medical Oncology, Alexander Fleming Cancer Institute, Buenos Aires, Argentina., Tanco DP; Department of Medical Oncology, Alexander Fleming Cancer Institute, Buenos Aires, Argentina., Waisberg F; Department of Medical Oncology, Alexander Fleming Cancer Institute, Buenos Aires, Argentina., Rodríguez A; Department of Medical Oncology, Alexander Fleming Cancer Institute, Buenos Aires, Argentina., Rizzo M; Clinical Oncology Unit, Hospital Universitario Austral, Pilar Buenos Aires, Argentina; Laboratorio de Inmuno-biología del Cáncer, Instituto de Investigaciones en Medicina Traslacional, Universidad Austral-Consejo Nacional de Investigaciones Científicas y Tecnologicas (CONICET), Buenos Aires, Argentina., Minatta N; Clinical Oncology Unit, Hospital Universitario Austral, Pilar Buenos Aires, Argentina., Rafael P; Clinical Oncology Unit, Hospital Universitario Austral, Pilar Buenos Aires, Argentina., Basbus L; Departamento de Oncología, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina., Lupinacci L; Departamento de Oncología, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina., Kaen D; Departamento de Oncología, Hospital de Clínicas Virgen María de Fátima, National University of La Rioja, La Rioja, Argentina., Ramos M; Departamento de Oncología, Hospital Alemán, Buenos Aires, Argentina., Bluthgen V; Departamento de Oncología, Hospital Alemán, Buenos Aires, Argentina., Castagneris N; Medical Oncology Unit, Reina Fabiola University Clinic, Universidad Católica de Córdoba, Córdoba, Argentina., Coppola MP; Departamento de Oncología, Hospital Zonal Especializado en Agudos y Crónicos Dr. Antonio Cetrangolo, Buenos Aires, Argentina., Scocimarro A; Departamento de Oncología, Hospital Zonal Especializado en Agudos y Crónicos Dr. Antonio Cetrangolo, Buenos Aires, Argentina., Guerra MF; Departamento de Oncología, Angel Roffo Oncology Institute, Universtiy of Buenos Aires, Buenos Aires, Argentina., Perfetti A; Department of Medical Oncology, Center for Medical Education and Clinical Research Norberto Quirno (CEMIC), Buenos Aires, Argentina., Levit P; Department of Medical Oncology, Unión Personal-Accord Salud, Buenos Aires, Argentina., Galvez-Nino M; Clinical Research Unit, Auna Ideas, Lima, Perú., Mas L; Department of Medical Oncology, Oncosalud - Auna, Lima, Perú; Latin American Cansortium for Lung Cancer Research., Rojas L; Luis Carlos Sarmiento Angulo Cancer Treatment and Research Center - CTIC, Direction of Research and Education/Thoracic Oncology Functional Unit, Bogotá, Colombia., Zuluaga J; Luis Carlos Sarmiento Angulo Cancer Treatment and Research Center - CTIC, Direction of Research and Education/Thoracic Oncology Functional Unit, Bogotá, Colombia., Chacón M; Department of Medical Oncology, Alexander Fleming Cancer Institute, Buenos Aires, Argentina., Corrales L; Departamento de Oncología, Centro de Investigación y Manejo del Cáncer (CIMCA), San José, Costa Rica; Latin American Cansortium for Lung Cancer Research., Samtani S; Departamento de Oncología, Clínica Las Condes Santiago, Las Condes, Chile., Arrieta O; Departamento de Oncología, Instituto Nacional de Cancerología (INCan), México City, México; Latin American Cansortium for Lung Cancer Research., Cardona A; Luis Carlos Sarmiento Angulo Cancer Treatment and Research Center - CTIC, Direction of Research and Education/Thoracic Oncology Functional Unit, Bogotá, Colombia; Latin American Cansortium for Lung Cancer Research., Remon J; Department of Cancer Medicine, Gustave Roussy, Villejuif, France., Martín C; Department of Medical Oncology, Alexander Fleming Cancer Institute, Buenos Aires, Argentina; Latin American Cansortium for Lung Cancer Research.
Publikováno v:
Clinical lung cancer [Clin Lung Cancer] 2024 Sep 21. Date of Electronic Publication: 2024 Sep 21.
Autor:
Guerra-Veloz MF; Institute of Liver Studies, King's College Hospital, London, UK., Soliman R; Institute of Liver Studies, King's College Hospital, London, UK., Agarwal K; Institute of Liver Studies, King's College Hospital, London, UK.
Publikováno v:
Expert review of anti-infective therapy [Expert Rev Anti Infect Ther] 2024 Aug; Vol. 22 (8), pp. 609-611. Date of Electronic Publication: 2023 Sep 11.
Autor:
Ajaz S; Institute of Liver Disease, Kings College Hospital, Denmark Hill, London SE5 9RS, UK., Chamley M; North Wood Group Practice Clinical Lead, Lambeth Diabetes Intermediate Care Team, London, UK., Lok J; Institute of Liver Disease, Kings College Hospital, London, UK., Soliman R; Institute of Liver Disease, Kings College Hospital, London, UK., Khan R; Institute of Liver Disease, Kings College Hospital, London, UK., Ahir K; Institute of Liver Disease, Kings College Hospital, London, UK., Curtis M; Institute of Liver Disease, Kings College Hospital, London, UK., Guerra-Veloz MF; Institute of Liver Disease, Kings College Hospital, London, UK., Agarwal K; Institute of Liver Disease, Kings College Hospital, London, UK.
Publikováno v:
Therapeutic advances in chronic disease [Ther Adv Chronic Dis] 2024 Jul 30; Vol. 15, pp. 20406223241264539. Date of Electronic Publication: 2024 Jul 30 (Print Publication: 2024).
Autor:
Shah S; Institute of Liver Studies, King's College Hospital, Denmark Hill, London, SE5 9RS, UK.; Pharmacy Department, Kings College Hospital, Denmark Hill, London, SE5 9RS, UK., Guerra Veloz MF; Institute of Liver Studies, King's College Hospital, Denmark Hill, London, SE5 9RS, UK., Agarwal K; Institute of Liver Studies, King's College Hospital, Denmark Hill, London, SE5 9RS, UK., Cannon M; Institute of Liver Studies, King's College Hospital, Denmark Hill, London, SE5 9RS, UK.
Publikováno v:
JHEP reports : innovation in hepatology [JHEP Rep] 2024 Apr 07; Vol. 6 (11), pp. 101093. Date of Electronic Publication: 2024 Apr 07 (Print Publication: 2024).